Robert Gundel

Robert Gundel

Nessuna posizione attualmente
Health Technology
Consumer Services
Finance

Profilo

Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.

Precedenti posizioni note di Robert Gundel

SocietàPosizioneFine
PROMIS NEUROSCIENCES, INC. Amministratore Delegato 29/06/2015
SCORPIUS HOLDINGS, INC. Direttore Tecnico/Scientifico/R&S 01/01/2009
Direttore Tecnico/Scientifico/R&S 01/11/2008
Direttore Tecnico/Scientifico/R&S 01/01/2008
Corporate Officer/Principal 01/01/2007
Vedi nel dettaglio l'esperienza di Robert Gundel

Formazione di Robert Gundel

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

24

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Robert Gundel
-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA